An agreement on funding stem cell research is closer than previously thought. A change in direction on financing stem cell research by US President Barack Obama has excited the American scientific community, starting with the major universities in California, including the San Francisco State, San Jose’ University, Stanford, and Berkeley. This time it will be the California Institute of Regenerative Medicine (CIRM) to open its wallet, ready to fund grants worth 58 million dollars to groups and researchers studying stem cells.
“Behind the embryonic stem cell war is just a war of patents,” led an article in the Osservatore Romano newspaper by Angelo Vescovi, a geneticist at the Niguarda Hospital in Milan and a professor at the Università Bicocca, who has always been against embryonic stem cell research and supporter of ‘law 40’ (recently declared unconstitutional by authorities).
“The production of embryonic stem cells by reprogramming adult cells discovered recently is not only better than methods that use human embryos, but is also based on new techniques, which are not protected by patents that currently govern the use of stem cells
Image via Wikipedia
Misleading advertisements by Swedish company Labo promising hair growth and to remove wrinkles have been pulled. The jury of the self-regulating body for the advertising industry (IAP) ordered the advertisements, which were found in two important Italian newspapers, to be stopped since they were “in violation of article 2 of the self-regulatory code for advertisements”.
According to the group’s conclusions (ruling number 13/09), the statements made in the message, as noted by the IAP Surveillance Committee, “did not overstate, they were misleading”.
This is due to the fact that “they were characterized by a technical and scientific language
Image via Wikipedia
In the decades-long war on cancer, as of late, researchers had been making little progress in comparison to colleagues treating other conditions, such as cardiac or infectious diseases. “Cancer research has really plateaued out,” William Matsui, an associate professor of oncology at Johns Hopkins University‘s School of Medicine, said at the 2009 World Stem Cell Summit here on Tuesday. But pushing cancer stem cell research “gives us a novel way to study cancer,” said Matsui, who also runs a lab at the university’s Sidney Kimmel Comprehensive Cancer Center.
Cancer and stem cells have had a fraught relationship—not in
Image by Marcos (In the fast lane) via Flickr
A new technique has shown that allowing embryonic stem cell research and having laws that regulate and monitor this type of research does not prevent the development of less ethically controversial techniques, rather, it creates incentives for them. In Valencia, at the same clinic where the first Spanish embryonic stem cell lines were obtained, the same researcher who developed the lines has obtained embryonic stem cells without destroying the embryo.
The announcement was made by Carlos Simòn, making the Centro de Investigaciòn Prìncipe Felipe (CSPF) the third laboratory in the world